.Two #postdoc positions available @MDAndersonNews. Join me and a team of world experts to fight #lungcancer via #Simulation & #mathematical #modeling and #optimization.👇 #AcademicTwitter #hiring #JuliaLang #R #decisionmaking #DataScience #INFORMS #socmdm #HEOR #CISNET #Analytics

[NEW OPPORTUNITY] The Job Market Showcase Track is a new initiative at the INFORMS Annual Meeting, and provides an opportunity for recent and soon-to-be graduates to present their research and engage with potential employers. https://t.co/zoLmstk2mM

Thankful to the @GYNCancer for the support!

Very proud of my postdoctoral fellow Sayaka Ishizawa for receiving the @GYNCancer FWC Grant to advance early detection of #ovariancancer using mathematical models. Congratulations Sayaka!

Thankful to all the co-authors for their contributions: @BobVolkPhD, @amlopezo, Renu Sara Nargund, Sara Nofal, Sayaka Ishizawa, Elisa Douglas. @MDAndersonNews

To ensure successful implementation of risk-based cancer screening several barriers at multiple levels (public, health-care professional, and system levels) need to be addressed.

In this newly published research we found that health care providers and the general public viewed personalized risk-based cancer screening as a logical next step to increase the quality of patient care and improve cancer mortality. Read more 👇 https://t.co/vOdVRPX3qI

Excited to attend the annual meeting of the American Cancer Society’s National Lung Cancer Roundtable. Looking forward to seeing old & meeting new colleagues and friends who share the same vision of minimizing the burden of lung cancer via screening & early prevention. #NLCRT2024

November is #LungCancerAwarenessMonth. At the @AmericanCancer National Lung Cancer Roundtable, we believe collective action is key to reducing the burden of lung cancer. Learn how our member organizations are tackling critical issues across the continuum: https://t.co/PU5lPFqP0e

This study was led by Mehdi Hemmati, in collaboration with Sayaka Ishizawa, Rafael Meza, Martin Tammemagi, Sam Hanash, Andrew Schaefer, Mara Antonoff, and Edwin Ostrin. Strategies were benchmarked against the ENGAGE framework & ranked in terms of their effectiveness & efficiency

In this new study published in eClinicalMedicine, we showed that lung cancer screening programs with adaptive screening frequency warrant further consideration, especially in settings with limited resources. @MDAndersonNews @maraantonoff @phlegmMDPhD

Important insights on #ovarian cancer preclinical phase may explain why annual screening is not effective in reducing mortality. Read more in our recent paper 👇 https://t.co/UFsHqoL6IY @LarissaAMeyerMD @karenluMD @MDAndersonNews

I am very happy and honored to be included in the IDSO's inaugural cohort of affiliates. Eager to interact and collaborate on projects aiming to develop and apply mathematical models and data science to enhance decision making across the cancer care continuum. @MDAndersonNews

In this newly published paper from the ToumazisLab we showed that head & neck #cancersurvivors are at a high risk of developing second primary #lungcancer. Personal history of cancer warrants further consideration as a criterion for #lungcancerscreening.

I am excited to share our new publication from the Toumazis Lab focusing on the Acceptability of Personalized Lung Cancer Screening. PCPs are willing to implement a personalized screening program if it's time efficient @BobVolkPhD @MDAndersonNews

Such a well deserved recognition for Dr Feuer. Thankful for his leadership and vision that created CISNET, which informed numerous cancer prevention guidelines over the years.

Congratulations to @CenterTobacco & #CISNET investigator @jamie_tam for winning the @srntorg 2023 Jarvik-Russell award. #SRNT2023

Thankful to @CPRITTexas for supporting our new research project focusing on improving uptake and adherence to #lungcancer screening. Grateful to @BobVolkPhD for including me and excited with the opportunity to work with @LMLowensteinPhD, Dr. Sanjay Shete and Dr. Myrna Godoy

New #CISNET publication: Selecting people for #lungcancer screening based on their risk is cost-effective & may yield higher QALYs and cost savings when compared to the 2021 #USPSTF guidelines. #CancerAwareness #ldct #prevention #PrecisionMedicine #personalized #cancercare

New research from our Dr. Iakovos Toumazis shows why risk model-based lung cancer screening strategies, which select based on personal risk, are more cost effective than current recommendations based solely on age and smoking history. https://t.co/aseFSINRwq @IToumazis #EndCancer

The range of risk thresholds is sensitive to the adherence rates, the anxiety level associated with false-positives, indeterminate findings, and regular screening exams but remains more cost-effective vs the USPSTF recommendations.